Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

J&J synthesizes H3 receptor antagonist with wake-promoting effects in rats

Feb. 28, 2005

Roche discloses new mGluR5 receptor antagonists for anxiety and pain

Feb. 25, 2005

Memory adds PDE10A inhibitor program to pipeline

Feb. 25, 2005

Codevelopment agreement for tramadol hydrochloride in Japan

Feb. 24, 2005

Hadasit researchers disclose a uPA-derived octapeptide for the treatment of MS

Feb. 23, 2005

The use of novel beta-secretase inhibitors for Alzheimer's disease claimed by GSK

Feb. 23, 2005

European approval for Azilect

Feb. 23, 2005

Prialt approved in Europe

Feb. 23, 2005

Rasagiline treatment benefits levodopa-treated Parkinson's disease patients

Feb. 23, 2005

Henry Ford Hospital studies Viagra for stroke recovery

Feb. 23, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...